Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia - GlobeNewswire https://t.co/aCc8wrmqNQ
— IDRO (@IDROOhio) March 1, 2019
from Twitter https://twitter.com/IDROOhio
February 28, 2019 at 11:29PM
No comments:
Post a Comment